Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication

NCT04660123 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT04660123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04660123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Phase 4
Overall status
Completed
Start date
December 20, 2020
Completion date
December 30, 2021
Enrollment
959 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bismuth, gastric cancer, helicobacter pylori infection